| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.1 | 0.07 |